My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pfizer (NY:PFE)

25.85 +0.05 (+0.19%)

Official Closing Price Updated: 7:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Discover which S&P500 stocks are making waves on Tuesday. ↗

September 30, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Pfizer Shares Gain Amid Reports Of Deal With The US Government ↗

September 30, 2025

Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.

Via Talk Markets

Topics Government

Trump Announces Pfizer Drug-Pricing Deal, Company To Invest $70 Billion in US Manufacturing ↗

September 30, 2025

Via Stocktwits

Topics Government

Why Pfizer Stock Just Popped ↗

September 30, 2025

Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers.

Via The Motley Fool

Topics Government

Pfizer Shares Are Trading Higher Tuesday: What's Going On? ↗

September 30, 2025

Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.

Via Benzinga

Topics Government

Trump To Announce Drug-Pricing Pact With Pfizer Later Today: Report ↗

September 30, 2025

According to a report by The Washington Post, the deal would require Pfizer to voluntarily offer its medications through Medicaid at reduced prices.

Via Stocktwits

Topics Government

Wall Street Defies D.C. Drama: Strong Gains Persist Amidst Looming Government Shutdown

September 30, 2025

As the clock ticks towards the critical September 30, 2025, fiscal year-end deadline, Washington D.C. finds itself embroiled in familiar budget battles, once again raising the specter of a U.S....

Via MarketMinute

Topics Economy Regulatory Compliance Stocks

US Government Shutdown Looms: Market Braces for Impact on S&P 500, Dow, and Nasdaq

September 30, 2025

As of late September 2025, the specter of a US government shutdown casts a long shadow over financial markets, prompting an immediate atmosphere of caution and uncertainty. With the fiscal year-end...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Global Trade Tensions Unleash Volatility in Stock Futures: A Deep Dive into Tariff-Driven Market Ripples

September 30, 2025

The global financial markets are currently navigating a tumultuous period, largely driven by an escalating wave of new trade tariffs. As of September 30, 2025, a series of aggressive trade policy...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out ↗

September 30, 2025

The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.

Via The Motley Fool

Dollar Dips as Government Shutdown Looms: A Volatile Start to Q4 2025

September 29, 2025

The US dollar experienced a notable weakening against major global currencies today, September 29, 2025, marking a significant shift after a period of sustained strength. This decline is largely...

Via MarketMinute

Topics Bonds Economy Government

Global Markets Brace for Impact as US Government Shutdown Looms

September 29, 2025

Washington D.C. – Global financial markets are once again gripped by uncertainty as a potential United States government shutdown looms, threatening to disrupt critical economic data releases and send...

Via MarketMinute

Topics Bonds Economy Workforce

These S&P500 stocks are the most active in today's session ↗

September 29, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

September 29, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Via Benzinga

Topics ETFs

Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience

September 29, 2025

As the U.S. government teeters on the brink of another shutdown, a seemingly counter-intuitive phenomenon is gripping financial markets: Dow futures are not only holding steady but are showing signs of...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing

September 29, 2025

Via PRLog

Topics Artificial Intelligence

U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears

September 29, 2025

As the clock ticks towards the September 30, 2025, funding deadline, the United States federal government finds itself perilously close to another shutdown. Congressional leaders remain deadlocked on a...

Via MarketMinute

Topics Bonds Economy Government

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus ↗

September 29, 2025

The takeover candidate is working on a bispecific antibody, capable of simultaneously blocking two drivers of cancer.

Via Investor's Business Daily

Topics Government

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income ↗

September 29, 2025

Right now, these dividend payers are top options for folks who like to set it and forget it.

Via The Motley Fool

Topics Artificial Intelligence Economy

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.

Via Benzinga

Topics Government World Trade

Inside MrBeast's $5 Billion Generosity Machine — and the Hidden Costs Behind It ↗

September 28, 2025

Internet sensation Jimmy Donaldson, better known as MrBeast, has successfully established an entertainment empire valued at over $5 billion.

Via Benzinga

Why Pfizer's Post-COVID Future Looks Brighter Than Ever ↗

September 28, 2025

A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

Via The Motley Fool

BridgeBio, Up 80% This Year, Just Unveiled Promising News For Its Pfizer Rival ↗

September 28, 2025

The company ran an exploratory analysis of its drug, Attruby, in patients with cardiomyopathy due to TTR amyloidosis.

Via Investor's Business Daily

Down 55%, Should You Buy the Dip on Pfizer? ↗

September 28, 2025

Pfizer is facing a patent cliff and has a high payout ratio, but it is taking steps to get back on track.

Via The Motley Fool

Topics Intellectual Property

5 Dividend Powerhouses to Buy and Never Sell ↗

September 28, 2025

These blue-chip giants have paid shareholders through wars, recessions, and pandemics.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers

September 27, 2025

In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...

Via MarketMinute

Topics Economy Intellectual Property

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

September 27, 2025

Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising...

Via MarketMinute

Topics Economy Intellectual Property

US Government Braces for Unprecedented Shutdown: Economic Fallout Looms as Deadline Nears

September 27, 2025

As the clock ticks towards midnight on September 30, 2025, the United States government stands on the precipice of a highly imminent and seemingly unavoidable shutdown. With just days left until the...

Via MarketMinute

Topics Economy Government Workforce

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? ↗

September 27, 2025

The company continues to improve its pipeline.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.